Dual beta2-adrenoceptor agonists-PDE4 inhibitors for the treatment of asthma and COPD.
Article Details
- CitationCopy to clipboard
Shan WJ, Huang L, Zhou Q, Jiang HL, Luo ZH, Lai KF, Li XS
Dual beta2-adrenoceptor agonists-PDE4 inhibitors for the treatment of asthma and COPD.
Bioorg Med Chem Lett. 2012 Feb 15;22(4):1523-6. doi: 10.1016/j.bmcl.2012.01.013. Epub 2012 Jan 14.
- PubMed ID
- 22297114 [ View in PubMed]
- Abstract
We designed and synthesized a novel class of dual pharmacology bronchodilators targeting both beta(2)-adrenoceptor and PDE4 by applying a multivalent approach. The most potent dual pharmacology molecule, compound 29, possessed good inhibitory activity on PDE4B2 (IC(50)=0.278 muM, which was more potent than phthalazinone, IC(50)=0.520 muM) and possessed excellent relaxant effects on tracheal rings precontracted by histamine (pEC(50)=9.3).
DrugBank Data that Cites this Article
- Binding Properties
Drug Target Property Measurement pH Temperature (°C) (R)-Rolipram cAMP-specific 3',5'-cyclic phosphodiesterase 4B IC 50 (nM) 500 N/A N/A Details